News - 03 Feb `20Emerging drugs for the treatment of vitiligo

New

Our co-authored paper titled Emerging drugs for the treatment of vitiligo has been published in the journal Expert Opinion on Emerging Drugs.

This study comprehensively summarizes the current concepts in the pathogenesis of vitiligo with special focus on the cytokine and signaling pathways, which are the targets for newer drugs. JAK kinase signaling pathways and the cytokines involved are the focus of vitiligo treatment in current research, followed by antioxidant and repigmenting mechanisms, basic fibroblast growth factors, afamelanotide and targeted immunotherapy.

For more information about emerging treatments for vitiligo, check out Drug Pipelines or Trials Hub sections of our website.

We also recommend reading our exclusive Vitiligo Drug Pipeline Analysis and Market Insights

 

      FAQOther Questions

      • Can chemicals cause vitiligo?

        It’s important to remember there are multiple factors involved in vitiligo onset, including genetic predisposition, living and working environments, and exposure to certain chem...

      • What causes vitiligo?

        Surprisingly, the causes of vitiligo are yet to be precisely established. Researchers know the cause is pre-wired in your genes, just waiting for a bad luck moment. In about hal...

      • How can I explain vitiligo to my children?

        Vitiligo can be puzzling for a child because a person who has it isn't "ill" in a common sense.  To choose the right words to explain vitiligo diagnosis to a child, first consi...